Continued aspirin treatment safe with partial nephrectomy

April 25, 2016

(HealthDay)—Continuing aspirin for chronic antiplatelet therapy is safe in patients undergoing laparoscopic partial nephrectomy, according to a study published in the April issue of The Journal of Urology.

David A. Leavitt, M.D., from the Hofstra North Shore LIJ School of Medicine in New Hyde Park, N.Y., and colleagues evaluated perioperative outcomes among 430 consecutive patients undergoing laparoscopic partial nephrectomy (January 2012 to October 2014). Patients were stratified between whether they continued or stopped treatment preoperatively.

The researchers found that among 101 patients (23.4 percent) on chronic aspirin , 17 continued antiplatelet treatment (16.8 percent). One patient in the aspirin group developed bleeding postoperatively and required angioembolization. In the off-aspirin cohort, one was observed. There were no significant differences in the incidence of major postoperative complications, intraoperative blood loss, transfusion rate, length of hospital stay, or rehospitalization rate. Continued aspirin use was tied to significantly increased operative time (181 versus 136 minutes; P = 0.01).

"Laparoscopic partial nephrectomy is safe and effective in on chronic antiplatelet therapy who require perioperative aspirin for cardioprotection," the authors write.

Explore further: OK to continue aspirin therapy up to pancreatic surgery

More information: Abstract
Full Text

Related Stories

OK to continue aspirin therapy up to pancreatic surgery

August 1, 2013
(HealthDay)—Patients on aspirin therapy do not have higher rates of perioperative bleeding, transfusion, or major procedure-related complications following elective pancreatic surgery, according to research published online ...

Long duration dual antiplatelet treatment increases bleeding

October 1, 2015
(HealthDay)—Routine use of dual antiplatelet therapy (DAPT) beyond six months after second generation drug-eluting stent (DES) implantation yields mixed clinical results, according to a review published in the October issue ...

Research reveals aspirin is safe for heart surgery patients

February 25, 2016
A worldwide study led by Monash University clinician-researchers shows that patients who take aspirin before heart surgery are at no greater risk of bleeding or complications. 

Surveillance beats radical nephrectomy for small masses

September 25, 2015
(HealthDay)—Patients with small renal masses who have a radical nephrectomy are significantly more likely to experience up staging to a more advanced chronic kidney disease stage based on glomerular filtration rate ranges, ...

Review: Short vs. long duration dual antiplatelet Tx after stent

June 5, 2015
(HealthDay)—Dual antiplatelet therapy (DAPT) continued beyond six months after drug-eluting stent implantation is associated with reduced stent thrombosis and myocardial infarction but also increased bleeding and all-cause ...

Prehospital antiplatelets improve graft intervention outcomes

January 28, 2013
(HealthDay)—Prehospital use of antiplatelet therapy, either aspirin/clopidogrel or dual antiplatelet therapy (DAPT), is associated with a lower incidence of major adverse cardiac events after saphenous vein graft (SVG) ...

Recommended for you

First proof a synthesized antibiotic is capable of treating superbugs

March 23, 2018
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.